Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2–7 months of age

This publication has 25 references indexed in Scilit:

• Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001-2003
  CMAJ : Canadian Medical Association Journal, 2005
• Immunogenicity and Reactogenicity of Four Doses of Diphtheria-Tetanus-Three-Component Acellular Pertussis-Hepatitis B-Inactivated Polio Virus-Haemophilus influenzae Type b Vaccine Coadministered with 7-Valent Pneumococcal Conjugate Vaccine
  The Pediatric Infectious Disease Journal, 2005
• Suppression and Modulation of Cellular and Humoral Immune Responses toHaemophilus influenzaeType B (Hib) Conjugate Vaccine in Hib–Diphtheria‐Tetanus Toxoids–Acellular Pertussis Combination Vaccines: A Study in a Rat Model
  The Journal of Infectious Diseases, 2005
• Population-Based Impact of Pneumococcal Conjugate Vaccine in Young Children
  Published by American Academy of Pediatrics (AAP) ,2004
• Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
  New England Journal of Medicine, 2003
• Safety and immunogenicity of a combination diphtheria-tetanus toxoids-acellular pertussis-hepatitis B vaccine administered at two, four and six months of age compared with monovalent hepatitis B vaccine administered at birth, one month and six months of age
  The Pediatric Infectious Disease Journal, 2002
• Magnitude of Interference after Diphtheria‐Tetanus Toxoids–Acellular Pertussis/Haemophilus influenzaeType b Capsular Polysaccharide–Tetanus Vaccination Is Related to the Number of Doses Administered
  The Journal of Infectious Diseases, 2001
• Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants
  The Pediatric Infectious Disease Journal, 2000
• Safety and Immunogenicity of Haemophilus influenzae‐Tetanus Toxoid Conjugate Vaccine Given Separately or in Combination with a Three‐Component Acellular Pertussis Vaccine Combined with Diphtheria and Tetanus Toxoids and Inactivated Poliovirus Vaccine for the First Four Doses
  Clinical Infectious Diseases, 1999
• An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay
  Journal of Immunological Methods, 1990